Retinal cyclic-GMP phosphodiesterase gamma-subunit: use of mutant synthetic peptides to define function.
Previously, we have domain-mapped the 87 amino acid PDE gamma inhibitory subunit of the retinal phosphodiesterase (PDE) alpha beta gamma 2 complex using synthetic peptides (1). The PDE gamma subunit has a binding domain for transducin-alpha (T alpha) and for PDE alpha/beta within residues #24-45. An inhibitory region for PDE alpha/beta is within residues #80-87. In order to establish the role of individual amino acids in the function of the PDE gamma inhibitory subunit, mutants were synthesized and utilized in PDE inhibition assays. The following mutants exhibited a decreased ability to inhibit PDE alpha/beta: Tyr84----Gly; Arg24----Gly; and Arg33----Pro. Sequence comparisons with cone PDE gamma indicate that there is identity within these functional regions.
Oppert
B
B
Department of Biochemistry, Kansas State University, Manhattan 66506.
Gonzalez
K
K
Hurt
D
D
Cunnick
J
J
Takemoto
D
D
D015106:3',5'-Cyclic-GMP Phosphodiesterases / Q000235:genetics* / Q000302:isolation & purification / Q000378:metabolism*; D000595:Amino Acid Sequence; D000818:Animals; D001665:Binding Sites; D002417:Cattle; D005091:Exons; D007700:Kinetics; D046911:Macromolecular Substances; D008969:Molecular Sequence Data; D016297:Mutagenesis, Site-Directed; D012374:Rod Cell Outer Segment / Q000201:enzymology*; D012689:Sequence Homology, Nucleic Acid; D012984:Software
D046911:Macromolecular Substances; D015106:3',5'-Cyclic-GMP Phosphodiesterases